F507-0002 Screening compound: N~3~-(3-chlorobenzyl)-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazole-3-carboxamide

F507-0002 Screening compound: N~3~-(3-chlorobenzyl)-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazole-3-carboxamide
F507-0002 Screening compound: N~3~-(3-chlorobenzyl)-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F507-0002
N~3~-(3-chlorobenzyl)-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F507-0002

Molecular Formula

C19H18ClN3O (C19 H18 ClN3 O)

Compound Name

N~3~-(3-chlorobenzyl)-1,2,3,4-tetrahydropyrido[1,2-a][1,3]benzimidazole-3-carboxamide

IUPAC name

n/a

SMILES

O=C(C1Cc2nc(cccc3)c3n2CC1)NCc1cccc(Cl)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

339.82

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.544

Distribution Coefficient, logD

3.538

Water Solubility, LogSw

-3.65

Polar Surface Area

35.853

Acid Dissociation Constant (pKa)

11.47

Base Dissociation Constant (pKb)

5.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.30

F507-0002 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with F507-0002 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F507-0002?
Check Price and Availability of F507-0002, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F507-0002 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F507-0002
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F507-0002
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F507-0002 available by request